Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, indicating a new release with potentially significant changes, while the previous version v2.9.7 has been removed.
    Difference
    0.3%
    Check dated 2024-07-23T15:14:14.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T09:14:20.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-11T01:40:14.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-10T01:05:21.000Z thumbnail image
  9. Check
    23 days ago
    Change Detected
    Summary
    The value 'Ovarian Epithelial Cancer Fallopian Tube Cancer' has been changed to 'Fallopian Tube Cancer Ovarian Epithelial Cancer'. This represents a reversal in the order of the cancer types listed in the study title.
    Difference
    0.2%
    Check dated 2024-07-03T16:25:00.000Z thumbnail image
  10. Check
    24 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T16:15:51.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.